OOral Oncology3/28/2026Combined positive score using 28–8 predicts nivolumab efficacy in HNSCCRyosuke Sato·Miki Takahara·Hiroki Komatsuda·Shota Sakaue·Hisataka Ominato·Michihisa Kono·Kan Kishibe·Hidekiyo Yamaki·Kenzo Ohara·Takumi Kumai·Risa Wakisaka·Takahiro Inoue·Mishie TaninoRead at Oral OncologyTagsCancer Immunotherapy and BiomarkersOncology
